Cytochrome P450 isoenzymes: Nursing considerations

Journal of the American Psychiatric Nurses Association

Volumn 5, Issue 1, 1999, Pages 15-22

  Applegate, Maureen ^a  

^a Indiana County Guidance Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0040476656     PISSN: 10783903     EISSN: None     Source Type: Journal    
DOI: 10.1177/107839039900500104     Document Type: Article

References (22)

1. Cadieux, RJ. (1993)- Geriatric psychopharmacology [Special report). Postgraduate Medicine, 93(4).
2. Carson, S.W. (1996). Pharmacokinetic and pharmacodynamic drug interactions with polypharmacotherapy of treatment-resistant affective and obsessive-compulsive disorders. Psychopharmacology Bulletin, 32, 555-567.
3. Daniel, H.I., & Edeki, T.I. (1996). Genetic polymorphism of Smephenytoin 4'-hydroxylation. Psychopharmacology Bulletin, 32, 219-230.
4. DeVane, C.L. (1994). Pharmacogenetics and drug metabolism of newer antidepressant agents. Journal of Clinical Psychiatry, 55(Suppl 12), 38-45.
5. DeVane, C.L., Spratt, E.G., & Sallee, F.R. (1997). Psychoactive drug-drug interactions in children, adolescents, and adults. Essential Psychopharmacology, 2(1), 33-50.
6. DuPont, R.L. (1997). The pharmacology and drug interactions of the newer antidepressants. Essential Psychopharmacology, 2(1), 7-32.
7. Ereshefsky, L. (1996). Drug-drug interactions involving antidepressants: Focus on venlafaxine. Journal of Clinical Psychopharmacology, 16 (Suppl. 2): 375-535.
8. Ereshefsky, L., & Tollefson, G.D. (1995). Exploring the risks of drug interactions: SSRIs and cytochrome. (Available from Pragmaton, 211 East Chicago Ave, Chicago, IL 606ll)
9. Glod, C.A. (1997). Antidepressants and the cytochrome P450 enzymes. Journal of the American Psychiatric Nurses Association, 2, 216-218.
10. Hollander, A.A., van Rooij, J., Lentjes, G AV., Arbouw, F., van Bree, J.B., Schoemaker, R.C., van Es, L.A., van der Woude, F.J., & Cohen, A.F. (1995). The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients. Clinical Pharmacology and nerapcutics, 57, 318-324.
11. Kellner, N.L., & Folks, D.G. (1997). Psychotropic drugs. St. Louis, MO: Mosby.
12. Keltner, N.L., Folks, D.G., Palmer, C.A., & Powers, R.E. (1998). Psychobiological foundations of psychiatric care. St. Louis, MO: Mosby.
13. Lin, K., Poland, R.E., Wan, Y., Smith, M.W., & Lesser, I.M. (1996). The evolving science of pharmacogenetics: Clinical and ethnic perspectives. Psychopharmacology Bulletin, 32, 205-217.
14. Malseed, R.T., Goldstein, F.J., & Balkon, W. (1995). Pharmacology: Drug therapy and nursing considerations (4th ed.). Philadelphia: Lippincott.
15. Michalets, E.L. (1998). Update: clinically significant cytochrome P450 drug interactions. Pharmacotherapy, 18, 84-112.
16. Nemeroff, C.B. (1994). Evolutionary trends in the pharmacotherapeutic management of depression. Journal of Clinical Psychiatry, 55(Suppl. 12), 3-15.
17. Nemeroff, C.B., DeVane, C.L., & Pollock, E.G. (1996). Newer antidepressants and the cytochrome P450 system. American Journal of Psychiatry, 153, 311-320.
18. Pollock, B.C. (1997). The endocrine-treatment interface: Gender differences in psychotropic drug metabolism. Psychopharmacology Bulletin, 33, 235-240.
19. Shen, WAV., & Lin, K. (1991). Cytochrome P450 monooxygenases and interactions of psychotropic drugs. International Journal of Psychiatry in Medicine, 21, 47-56.
20. Slaughter, R.L., & Edwards, DJ. (1995). Recent advances: The cytochrome P450 enzymes. The Annals of Pbarmacotberapy, 29, 619-624.
21. Wheatley, M.D., van Moffaert, M., Timmerman, L, & Kremer, C.M.E. (1998). Mirtazapine: Efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Journal of Clinical Psychiatry, 59, 306-312.
22. Yonkers, K.A., Kando, J.C., & Hamilton, J. (1996). Gender issues in psychopharmacologic treatment. Essential Psychopharmacology, 7(1), 54-69.